Thursday, May 30, 2019

Damaged sense of smell fixed in mice by squirting stem cells up nose

Stem cell therapy delivered through nasal droplets can restore a sense of smell in mice – but it will take time to develop a safe nasal spray for humans

from New Scientist - Health http://bit.ly/2HJTPgG
via IFTTT

IoT risk assessment means all hands on deck

The wide array of connected devices means "lot of different stakeholders that need to coordinate," on both the clinical and IT side. That requires "process and due diligence.

from News from healthcareitnews.com http://bit.ly/2EIAtX8
via IFTTT

Topical treatment helps prevent actinic keratosis from developing into skin cancer

Actinic keratoses are small, red, scaly spots that can feel like dry, sandpapery skin. They are a direct result of ultraviolet radiation, which is why they most commonly occur in sun-exposed areas, such as the face, forearms, and hands.

Why are actinic keratoses a concern? If left untreated, some actinic keratoses can develop into squamous cell skin cancers. Actinic keratosis can develop in almost 40% of white patients older than 50, making it the most common precancerous skin condition in this population. It is also one of the most common reasons for which people visit a dermatologist.

Field-directed treatments for multiple actinic keratoses

Cryotherapy, or the targeted use of liquid nitrogen, is commonly used to treat individual lesions. But what if there are many actinic keratoses scattered all over the face or hands? This is when field-directed therapy — using a treatment method to treat an entire area of skin — can be helpful.

There are several field-directed therapies available.

  • A topical cream containing fluorouracil, a chemotherapy drug, works by disrupting DNA synthesis in and thereby destroying actinic keratosis cells. It can be applied at home and is typically used twice a day for two to four weeks.
  • Topical imiquimod cream stimulates a local immune response in the skin, leading to destruction of the actinic keratosis cells. It can be applied at home and is typically used two to three times a week for up to 16 weeks, making this a longer course of treatment compared to topical fluorouracil.
  • Topical ingenol mebutate gel injures two important components of actinic keratosis cells — mitochondria (the cells’ powerhouses) and plasma membranes (the cells’ gatekeepers) — leading to destruction of the cells. It is typically applied at home for three consecutive days. While convenient, many prescription plans do not cover this medication, making the out-of-pocket cost quite expensive.
  • Photodynamic therapy uses light to activate a drug that is applied to the skin. This leads to destruction of actinic keratosis cells. This is an in-office procedure that is performed in one afternoon. It is a good option for those who prefer not to apply creams at home.

All of these therapies are frequently used by dermatologists, but there are no clear guidelines on which treatment is preferred.

New study compares effectiveness of field-directed treatments

An exciting study recently published in the New England Journal of Medicine sought to determine how effectively each of these four field-directed therapies treats multiple actinic keratoses. In this study, 624 patients with multiple actinic keratoses were randomized to treatment with one of the four aforementioned field-directed treatments.

The primary endpoint of the study was the percentage of patients who had at least 75% reduction in their number of actinic keratoses after one year. The study found that the percentage of patients who achieved this goal was significantly higher in people treated with topical fluorouracil (75%), compared to those treated with topical imiquimod (54%), photodynamic therapy (38%), and topical ingenol mebutate (29%).

This seminal study highlights the important role of field-directed treatment of actinic keratosis in decreasing a person’s risk of developing squamous cell skin cancers.

While this study found topical fluorouracil cream to be the most effective agent, other treatments may still have a role; each treatment has advantages and disadvantages in terms of time and cost, which may influence individual preferences. If you have multiple actinic keratoses, speak to your dermatologist to determine which treatment is the right choice for you.

Follow me on Twitter @KristinaLiuMD

The post Topical treatment helps prevent actinic keratosis from developing into skin cancer appeared first on Harvard Health Blog.



from Harvard Health Blog http://bit.ly/2JMXGMh
via IFTTT

TB outbreak: Residents offered screening at Llwynhendy

There are 29 cases in a village - including one death - and people are advised to get checked.

from BBC News - Health https://bbc.in/2EIOCUj
via IFTTT

Health data security exposures doubled in one year, report says

Research from Digital Shadows found imaging files particularly vulnerable.

from News from healthcareitnews.com http://bit.ly/2W0PRUW
via IFTTT

How to Get Kids to Wear Sunscreen

How to Get Kids to Wear SunscreenBeing a kid in the summer is often about playing outside, but if you don’t protect your child from the sun’s ultraviolet rays, he or she has a greater chance of developing skin cancer as an adult...




from Yahoo News - Latest News & Headlines https://yhoo.it/2WaVm8p
via IFTTT

Psychiatrists call for warnings over antidepressant withdrawal

Some patients can suffer severe symptoms if they come off the drugs too quickly, doctors say.

from BBC News - Health https://bbc.in/2I6RAmH
via IFTTT

Instagram: 'I don't want people to be ashamed of their scars'

People with a history of self-harm discuss Instagram's rules over removing images showing healed scars.

from BBC News - Health https://bbc.in/2HLBsYH
via IFTTT

'World's smallest' surviving premature baby released from US hospital

Baby Saybie was given just hours to live when she was born weighing just 245g (8.6oz) in San Diego.

from BBC News - Health https://bbc.in/2We3iWo
via IFTTT

Tieto launches first openEHR-based information systems in Finland

THE ROAD TO HELSINKI: At the HIMSS & Health 2.0 European Conference, Tieto will present the first openEHR-based information systems for Finnish healthcare.

from News from healthcareitnews.com http://bit.ly/2VWv3xD
via IFTTT

Open clinical data simplifies care chains

THE ROAD TO HELSINKI: Tieto has made a decision to base its Lifecare information system on openEHR, and will present the model at the HIMSS & Health 2.0 European conference in Helsinki this June.

from News from healthcareitnews.com http://bit.ly/2JLjFTK
via IFTTT

Wednesday, May 29, 2019

Congo's Ebola epidemic inflicts heavy toll on children

Eight-year-old Kennedy Muhindo was running a high fever and racked by stomach pain and diarrhea.


from Reuters: Health News https://reut.rs/2HJBhgz
via IFTTT